Mural Oncology Announces Scheme of Arrangement Completion and Acquisition.

Mural Oncology announces the effectiveness of its scheme of arrangement and completion of acquisition by XRA 5 Corp, a subsidiary of XOMA Royalty Corporation. The scheme, which acquired the entire issued and to be issued share capital of Mural, became effective on December 5, 2025. Distribution of cheques and crediting of DTC participant accounts for the cash consideration is expected to commence shortly.